Back to top

Astrana Health price target raised to $55 from $47 at Truist

Truist analyst Jailendra Singh raised the firm’s price target on Astrana Health (ASTH) to $55 from $47 and keeps a Buy rating on the shares. The fi...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Astrana Health, Inc. (ASTH)